R. Srinivasan

Die Arzneimittelforschung entwickelt sich durch die Integration neuer Technologien wie k nstliche Intelligenz (KI) und CRISPR rasch weiter. KI verbessert den Prozess der Arzneimittelentwicklung, indem sie eine schnellere und genauere Analyse biologischer Daten, eine optimierte Identifizierung von Leitstrukturen und die Vorhersage von Wechselwirkungen zwischen Arzneimitteln erm glicht. In der Zwischenzeit erm glicht die CRISPR-Technologie eine pr zise Genbearbeitung, was die Erforschung genetischer Krankheiten und die Entwicklung gezielter Therapien erleichtert. Zusammengenommen ver ndern diese Innovationen herk mmliche Methoden, verk rzen die Zeit und die Kosten f r die Markteinf hrung neuer Medikamente und ebnen den Weg f r eine personalisierte Medizin. Durch die Nutzung von Big Data und fortschrittlichen Biotechnologien k nnen Forscher die Krankheitsmechanismen besser verstehen und wirksamere Behandlungen entwickeln, was letztlich zu besseren Ergebnissen f r die Patienten f hrt.

La scoperta dei farmaci si sta rapidamente evolvendo con l'integrazione di tecnologie emergenti come l'intelligenza artificiale (AI) e CRISPR. L'intelligenza artificiale migliora il processo di sviluppo dei farmaci consentendo un'analisi pi rapida e accurata dei dati biologici, ottimizzando l'identificazione dei composti guida e prevedendo le interazioni tra farmaci. La tecnologia CRISPR, invece, consente un editing genico preciso, facilitando lo studio delle malattie genetiche e lo sviluppo di terapie mirate. Insieme, queste innovazioni stanno trasformando i metodi tradizionali, riducendo i tempi e i costi di immissione sul mercato di nuovi farmaci e aprendo la strada alla medicina personalizzata. Sfruttando i big data e le biotecnologie avanzate, i ricercatori possono comprendere meglio i meccanismi delle malattie e sviluppare trattamenti pi efficaci, migliorando in ultima analisi i risultati per i pazienti.

A descoberta de medicamentos est a evoluir rapidamente com a integra o de tecnologias emergentes, como a intelig ncia artificial (IA) e o CRISPR. A IA melhora o processo de desenvolvimento de medicamentos ao permitir uma an lise mais r pida e precisa dos dados biol gicos, optimizando a identifica o de compostos l deres e prevendo intera es medicamentosas. Entretanto, a tecnologia CRISPR permite a edi o precisa de genes, facilitando o estudo de doen as gen ticas e o desenvolvimento de terapias direcionadas. Em conjunto, estas inova es est o a transformar os m todos tradicionais, reduzindo o tempo e os custos de introdu o de novos medicamentos no mercado e abrindo caminho para a medicina personalizada. Ao tirar partido dos grandes volumes de dados e das biotecnologias avan adas, os investigadores podem compreender melhor os mecanismos das doen as e desenvolver tratamentos mais eficazes, melhorando, em ltima an lise, os resultados para os doentes.

Drug discovery is rapidly evolving with the integration of emerging technologies such as artificial intelligence (AI) and CRISPR. AI enhances the drug development process by enabling faster and more accurate analysis of biological data, optimizing lead compound identification, and predicting drug interactions. Meanwhile, CRISPR technology allows for precise gene editing, facilitating the study of genetic diseases and the development of targeted therapies. Together, these innovations are transforming traditional methods, reducing time and costs in bringing new drugs to market, and paving the way for personalized medicine. By leveraging big data and advanced biotechnologies, researchers can better understand disease mechanisms and develop more effective treatments, ultimately improving patient outcomes.

This book takes a practice approach to studying platform business models. Though the frameworks could be generalized, the book focuses on platform businesses, rather than societal platforms.

Medicinal plants have long been prized for their ability to support memory and brain health and provide an alternative to medications. From ancient civilizations to modern science, numerous medicinal plants are known for their neuroprotective and cognitive properties. Ginkgo biloba is obtained from one of the oldest living trees and forms the basis of traditional medicine. The flavonoids and terpenes it contains are known to improve cognitive function and memory by improving blood flow to the brain. Bacopa Monnieri is a well-known herb in Ayurvedic medicine, known for its ability to improve memory and learning abilities. The active compound, bacoside, is thought to support synaptic communication and protect neurons from oxidative stress. Rhodiola rosea, another plant highly regarded in Scandinavian and Chinese medicine, is known for its adaptogenic properties. Rhodiola rosea is known to be effective in supporting overall brain function by regulating the stress response, reducing mental fatigue, and improving cognitive function.

Borders, borderlands and frontiers emerged as critical academic discourse yet again at the beginning of 21st century. In earlier times, they invited scholarly examination within the broader fields of political geography and political science. However, the effects of globalization and the manifestation of global politics appear to have prompted the formulation of theories and postulations on borders according to it the status as a field of knowledge by itself. International migration, the protests for gender and other rights, and the wheels of economics affecting all walks of life suggest that borders must be appraised from political, economic and social dimensions as a subject of inter or multidisciplinary inquiry. South Asia perhaps invokes memories and contestations over borders quite unlike many other regions of the world. Colonial consequences, aspirations of nations and the footprints of global politics inside the region indeed merit an exclusive examination. Especially, India that is emerging as a major player in global arena, distressed with the fallouts of colonial occupation, needs a greater understanding from the multidimensional aspects that have now become part of the schools of thought on borders. This book attempts to bridge the knowledge gap on understanding borders in Indian context by exploring four distinct dimensions: physical, maritime, socio-cultural and security. With scholarly and practitioner contributions, this book provides a comprehensive appreciation of all the four dimensions taken for evaluation.